Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Compounding Theme Archive
PEDIATRICS AND GERIATRICS
PEDIATRICS AND GERIATRICS
A collection of Journal articles and formulations within one or more related compounding topics.

This archive contains the following articles listed by volume, issue and page number:

PEDIATRICS RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Prescription: Pediatric/Geriatric
Allen Loyd V Jr
Jul/Aug 2024
Pg. 268-269

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jul/Aug 2024
Pg. 282-285

Calculations: Pediatric Dosing Consideration
Stockton Shelly J
Jul/Aug 2024
Pg. 304-305

Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
Jul/Aug 2024
Pg. 309

Natural Head Lice Repellant Spray
Allen Loyd V Jr
Jul/Aug 2024
Pg. 312

Compounded "Monster Spray" for Nighttime Terrors: A Case Report
Riepl Mike
Nov/Dec 2023
Pg. 446-448

Calculations
Stockton Shelly J
Nov/Dec 2023
Pg. 488

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Calculations
Stockton Shelly J
Jul/Aug 2021
Pg. 318

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita
, Kojima Hiroki, Nakagawa Naoto
May/Jun 2021
Pg. 258-262

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Calculations
Stockton Shelly J
Jan/Feb 2021
Pg. 40

Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli
, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020
Pg. 408-412

Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
Sep/Oct 2019
Pg. 411

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina
, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019
Pg. 324-331

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
Jan/Feb 2019
Pg. 35-44

PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
Nov/Dec 2018
Pg. 444

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian
, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017
Pg. 426-429

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Mar/Apr 2017
Pg. 171-175

Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha
, Harger Beau, Estrada Nick
Jul/Aug 2016
Pg. 277-280

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
May/Jun 2015
Pg. 205-211

L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 146

Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe
, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Sep/Oct 2014
Pg. 427-431

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E
, Akbarian-Tefagh Jessica
Nov/Dec 2013
Pg. 446-450

Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
Sep/Oct 2013
Pg. 364-368

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Horace Alexis E
, Akbarian-Tefagh Jessica
Sep/Oct 2013
Pg. 388-391

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E
, Egharevba J O, Erhagbe B E, Okoh F
Sep/Oct 2013
Pg. 432-435

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients
Nolan Sara M
, Burgess Christopher A
Nov/Dec 2011
Pg. 446-448

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D
, Williams LaVonn
Nov/Dec 2011
Pg. 464-469

Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
Sep/Oct 2011
Pg. 358-366

Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
Sep/Oct 2011
Pg. 386-387

Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
Jul/Aug 2011
Pg. 316-319

Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
May/Jun 2011
Pg. 194-199

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom
, Goetsch Daniel
May/Jun 2011
Pg. 200-203

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
Mar/Apr 2011
Pg. 156

Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 518

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
Jul/Aug 2010
Pg. 270-274

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

When Traditional Medicine Fails
Bash Robert
Jan/Feb 2010
Pg. 6-8

Calculations
Stockton Shelly J
Jan/Feb 2010
Pg. 58-59

Emanuel Butt Paste
Allen Loyd V Jr
Sep/Oct 2009
Pg. 431

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L
, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009
Pg. 314-317

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
May/Jun 2009
Pg. 220-221

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R
, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009
Pg. 14-18

Calculations
Stockton Shelly J
Jan/Feb 2009
Pg. 63

Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
Jan/Feb 2009
Pg. 64

Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 65

Diaper Rash Cream with Miconazole
Allen Loyd V Jr
Jan/Feb 2009
Pg. 68

Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 69

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Benzyl Benzoate Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 261

Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2008
Pg. 269

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 73

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 249

Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
Mar/Apr 2007
Pg. 116-120

Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2007
Pg. 161

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Principles of Pediatric Palliative Care and Pain Control
Peralta Alexander Jr
Jan/Feb 2007
Pg. 10-15

Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine
, Moffett Brady S
Jan/Feb 2007
Pg. 17-19

Sevelamer Suspension in Children with End-Stage Renal Disease
McElhiney Linda F
Jan/Feb 2007
Pg. 20-24

Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
Jan/Feb 2007
Pg. 26-27

Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
Jan/Feb 2007
Pg. 27

Calculations
Stockton Shelly J
Jan/Feb 2007
Pg. 68

Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 69

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 71

Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 75

Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 76

Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 77

Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 78

Nitrazepam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 388

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 299

Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 302

Nifedipine 4-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 303

Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 304

Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 67

Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
Nov/Dec 2005
Pg. 410

Unlocking Autism: Is Compounding the Key?
Vail Jane
Nov/Dec 2005
Pg. 413-420

Compounding for a Pediatric Hospital
McElhiney Linda F
Nov/Dec 2005
Pg. 423-431

Wiping Out Diaper Rash
Fields Shannon W
Nov/Dec 2005
Pg. 433-434

View Sample
Pediatric Oral Liquid Preparations
Fonseca Simonne C
, Ferreira Anderson de O
Nov/Dec 2005
Pg. 437-442

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
Nov/Dec 2005
Pg. 487-488

Calculations
Prince Shelly J
Jan/Feb 2005
Pg. 57

Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S
, Mitra Pallabi
Jan/Feb 2005
Pg. 82-86

A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
Nov/Dec 2004
Pg. 458-460

Domperidone in Lactation: Use as a Galactagogue
Albright Lisa M
Sep/Oct 2004
Pg. 329-335

Head to Toe Solutions: A Quick Review of Current Therapies
Paoletti James E
Sep/Oct 2004
Pg. 345-352

Book and Literature Reviews
Reed-Kane Dana
, Foy Elizabeth, MacCara Mary E
Jul/Aug 2004
Pg. 244-249

Gag Tablet Lollipops
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 184

Amiodarone HCl 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 214

Atenolol 2-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 215

Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 218

Flucytosine 10-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 134

Griseofulvin 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 135

Stomatitis Mouthwash
Allen Loyd V Jr
Mar/Apr 2004
Pg. 140

Tacrolimus 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 141

Tiagabine 1-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 142

Sulfasalazine 250-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2003
Pg. 474

Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension
Haase Mark R
, Khan Mansoor A, Bonilla Jeremiah
Nov/Dec 2003
Pg. 485-489

Thioridazine HCl 100-mg/mL Concentrated Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 381

Isoniazid 10-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 376

Ursodiol 150-mg Capsules
Allen Loyd V Jr
Sep/Oct 2003
Pg. 382

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings
McElhiney Linda F
Sep/Oct 2003
Pg. 394-398

Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations
Okeke Claudia C
, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Jul/Aug 2003
Pg. 313-319

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

Excerpts from and Reviews of Current Published Literature: Pediatric Medications
Foy Elizabeth
, MacCara Mary E
Nov/Dec 2002
Pg. 423

Book Reviews: Compounding for Pediatric Patients
Ashworth Lisa D
, Reed-Kane Dana
Nov/Dec 2002
Pg. 424-425

Caffeine and Sodium Benzoate 250-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 449

Dimenhydrinate 50-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 451

Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2002
Pg. 367

Topical Secretin for the Treatment of Autism
King Erin
, Toney Steve
Nov/Dec 2001
Pg. 436-437

Basics of Compounding: Suspensions
Allen Loyd V Jr
Jul/Aug 2001
Pg. 294-297

Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Spironolactone Oral Suspension 2-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Progesterone Oral Suspension 40-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Xanthan Gum Oral Suspension Vehicle 0.3%
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Pediatric Preoperative Cocktail Injection
Allen Loyd V Jr
Jul/Aug 2001
Pg. 306

The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
May/Jun 2001
Pg. 198-201

The Basics of Compounding Emulsions, Part 1
Allen Loyd V Jr
Mar/Apr 2001
Pg. 120-123

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Flavoring: Compounding a Treat
Kloesel Lawson G
Jan/Feb 2001
Pg. 13-16

Autism in Children
Cave Stephanie
Jan/Feb 2001
Pg. 18-19

Methylphenidate in the Treatment of Attention Deficit Disorders
Tenreiro Kim
Jan/Feb 2001
Pg. 21-22

A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature
Foy Elizabeth
, MacCara Mary E
Jan/Feb 2001
Pg. 23-25

Compounding in History: Pediatric Considerations
Worthen Dennis B
Jan/Feb 2001
Pg. 30-31

Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
Jan/Feb 2001
Pg. 38

Cholestyramine 6.5% Ointment
Allen Loyd V Jr
Jan/Feb 2001
Pg. 42

Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
Jan/Feb 2001
Pg. 43

Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 44

Lorazepam 1-mg Chewable Gummy Gels
Allen Loyd V Jr
Jan/Feb 2001
Pg. 45

Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2001
Pg. 46

Natural Head Lice Repellant Spray
Allen Loyd V Jr
Jan/Feb 2001
Pg. 48

Niacinamide 4% Acne Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 49

Promethazine HCl 50-mg/mL in PLO Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 51

Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
Jul/Aug 2000
Pg. 289-293

Ondansetron HCl 8-mg/mL in PLO
Allen Loyd V Jr
Jul/Aug 2000
Pg. 305

Compounding Ear, Nose and Throat Preparations
Allen Loyd V Jr
May/Jun 2000
Pg. 164-169

Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
May/Jun 2000
Pg. 171-174

Sildenafil 0.2% Otic Drops
Holland Robert T
, Quisling Richard
May/Jun 2000
Pg. 175

Amphotericin B 100-mg Troches
Allen Loyd V Jr
May/Jun 2000
Pg. 208

Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles
Allen Loyd V Jr
May/Jun 2000
Pg. 214

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Mar/Apr 2000
Pg. 136

The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Allen Loyd V Jr
Nov/Dec 1999
Pg. 461-465

Linguet Base (Soft Lozenge)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Sorbitol Based Hard Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Sucrose Based Hard Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Polyethylene Glycol (PEG) Troches (Soft Lozenges)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 463

Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 463

Chewable Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 464

Methotrexate 2.5-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1999
Pg. 474

Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
Jul/Aug 1999
Pg. 274-276

Analysis of Extemporaneous Alprostadil Formulations
Sarver Jeffrey G
, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
Mar/Apr 1999
Pg. 148-155

Oral Ulceration Mouthwash
Allen Loyd V Jr
Jan/Feb 1999
Pg. 10

Alternatives for the Lactose-Intolerant Patient
Glasnapp Andrew
Nov/Dec 1998
Pg. 412

Pediatric Central Parenteral Nutrition Solution
Allen Loyd V Jr
Sep/Oct 1998
Pg. 368

Pediatric Central Parenteral Nutrition Solution with Heparin
Allen Loyd V Jr
Sep/Oct 1998
Pg. 369

Pediatric Peripheral Parenteral Nutrition Solution
Allen Loyd V Jr
Sep/Oct 1998
Pg. 370

Malathion Topical Lotion: Therapy for Resistant Head Lice
Glasnapp Andrew
, Nguyen Linh
Jul/Aug 1998
Pg. 268-269

Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration
Inagaki Kazuhiro
, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Jul/Aug 1998
Pg. 318-321

Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel
Allen Loyd V Jr
Mar/Apr 1998
Pg. 159

Vehicles for Compounding Oral Liquids: Some Practical Considerations
Palmer Henry A
Mar/Apr 1998
Pg. 160-161

Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Tenjarla Srini N
, Ward Earl S, Fox Janet L
Jan/Feb 1998
Pg. 83-88

Ketoconazole 20-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1997
Pg. 414

Baclofen 10-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 321

Captopril 0.75-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 322

Diltiazem HCl 12-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 1997
Pg. 323

Stability of Bethanechol Chloride Oral Liquid Dosage Forms
Gupta Vishnu D
, Maswoswe J
Jul/Aug 1997
Pg. 278-279

Allopurinol 20-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 174

Dipyridamole 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 176

Labetalol HCl 40-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 179

Metoprolol Tartrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 180

Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 183

Spironolactone 25-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 184

Verapamil HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 188

The Formulation Development and Stability of Spironolactone Suspension
Alexander Kenneth S
, Vangala Shyam Sundar KS, White Donald B, Dollimore David
May/Jun 1997
Pg. 195-199

The Formulation Development and Stability of Metronidazole Suspension
Alexander Kenneth S
, Vangala Shyam Sundar KS, Dollimore David
May/Jun 1997
Pg. 200-205

Metronidazole 15-mg/mL Suspension
Gupta Vishnu D
, Maswoswe J, Bailey RE
May/Jun 1997
Pg. 202

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89

Flavors and Flavoring
Allen Loyd V Jr
Mar/Apr 1997
Pg. 90-92

Compounded Suppositories and Pharmaceutical Care
Duncan-Hewitt Wendy
, Rains John
Mar/Apr 1997
Pg. 93-99

Acetazolamide 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 101

Azathioprine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 102

Flecainide Acetate 20-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 103

Methylcellulose 1% to 5% Solutions
Allen Loyd V Jr
Mar/Apr 1997
Pg. 104

Methylcellulose Oral-Liquid Vehicles
Allen Loyd V Jr
Mar/Apr 1997
Pg. 105

Pediatric Chewable Gummy Gel Base
Allen Loyd V Jr
Mar/Apr 1997
Pg. 106

Pediatric Chocolate Troche Base
Allen Loyd V Jr
Mar/Apr 1997
Pg. 106

Pediatric Chewable Gummy Gels
Allen Loyd V Jr
Mar/Apr 1997
Pg. 107

Pediatric Chocolate Troche
Allen Loyd V Jr
Mar/Apr 1997
Pg. 108

Nystatin Popsicles
Allen Loyd V Jr
Mar/Apr 1997
Pg. 109

Procainamide HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 110

Syrup NF
Allen Loyd V Jr
Mar/Apr 1997
Pg. 111

Tetracaine 20-mg Lollipops
Allen Loyd V Jr
Mar/Apr 1997
Pg. 112

Tetracycline Compound Troche
Allen Loyd V Jr
Mar/Apr 1997
Pg. 113

Xanthan Gum Suspension Vehicle (0.2% to 0.5%)
Allen Loyd V Jr
Mar/Apr 1997
Pg. 114

Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
Jan/Feb 1997
Pg. 13

HDDM Hard Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 29

HDDM Soft Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 30

HDDM Sugar Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 30

Metoclophen Nausea Suppositories
Allen Loyd V Jr
Jan/Feb 1997
Pg. 31

Metoclophen-Modified Nausea Suppositories
Allen Loyd V Jr
Jan/Feb 1997
Pg. 31

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Alexander Kenneth S
, Kothapalli Madhu R, Dollimor David
Jan/Feb 1997
Pg. 60-63

Return to Top

GERIATRICS RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Formulation and Optimization of Novel Antiaging Polyherbal Liposal Gel Using Central Composite Design
Amalu Mathew
, Roshita Mariate B, Honeymol George, J Tina, Gifty Jojo M
May/Jun 2025
Pg. 210-221

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
, Thompson Chad
Nov/Dec 2024
Pg. 455-458

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2024
Pg. 6-14

Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd
, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 512-521

Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah
, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 522-527

Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike
, Kaiser Joe
May/Jun 2023
Pg. 192-200

Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E
, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021
Pg. 464-467

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli
, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020
Pg. 408-412

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Mar/Apr 2017
Pg. 171-175

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2013
Pg. 28-38

Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John
, DollbaumCharles M
Mar/Apr 2011
Pg. 102-112

Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 243

PreScription: The Ages of Man
Allen Loyd V Jr
Mar/Apr 2010
Pg. 92

Emerging Evidence for Androgen Replacement Therapy in Aging Men
Bramwell Bethany L
Mar/Apr 2010
Pg. 94-99

PreScription: Geriatric Compounding: An Opportunity for Pharmacists
Allen Loyd V Jr
Nov/Dec 2009
Pg. 492

Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male
Biundo Bruce
Nov/Dec 2009
Pg. 494-496

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
Nov/Dec 2009
Pg. 498-505

Marketing the Geriatric Patient
Moore Renee
Nov/Dec 2009
Pg. 538-539

Calculations
Stockton Shelly J
Nov/Dec 2009
Pg. 545

Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
Jul/Aug 2009
Pg. 340

Arthritis Epidemiology Impacts Pharmacists
Vance Dwight A
Nov/Dec 2008
Pg. 476-480

Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G
, Abdulmohsin Saud
Jan/Feb 2008
Pg. 8-14

Calculations
Stockton Shelly J
Jan/Feb 2007
Pg. 68

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 71

Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 75

Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 76

Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 304

Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S
, Mitra Pallabi
Jan/Feb 2005
Pg. 82-86

Book and Literature Reviews
Reed-Kane Dana
, Foy Elizabeth, MacCara Mary E
Jul/Aug 2004
Pg. 244-249

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Atropine 1-mg Gelatin Troches
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 184

Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO)
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 185

Pain Management in the Elderly
Peralta Alexander Jr
May/Jun 2004
Pg. 187-191

Amiodarone HCl 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 214

Atenolol 2-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 215

Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 218

Flucytosine 10-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 134

Griseofulvin 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 135

Stomatitis Mouthwash
Allen Loyd V Jr
Mar/Apr 2004
Pg. 140

Tacrolimus 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 141

Tiagabine 1-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 142

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S
, Kaushik Sarita
Mar/Apr 2004
Pg. 147-152

Ergoloid Mesylate 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2003
Pg. 470

Perphenazine 2.5-mg/5-mL Syrup
Allen Loyd V Jr
Nov/Dec 2003
Pg. 473

Sulfasalazine 250-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2003
Pg. 474

Thioridazine HCl 100-mg/mL Concentrated Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 381

Isoniazid 10-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 376

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings
McElhiney Linda F
Sep/Oct 2003
Pg. 394-398

Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations
Okeke Claudia C
, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Jul/Aug 2003
Pg. 313-319

Levofloxacin 250-mg/5mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2003
Pg. 60

Ofloxacin 250-mg/5-mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2003
Pg. 60

Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2002
Pg. 367

Mild Laxative
Worthen Dennis B
May/Jun 2002
Pg. 185

Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel
Worthen Dennis B
May/Jun 2002
Pg. 185

Compounding for Geriatrics Patients
Armstrong Eldon
May/Jun 2002
Pg. 168-170

Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
May/Jun 2002
Pg. 171-176

Book Reviews: Wellness, Nutrition and Geriatrics
Reed-Kane Dana
, Ashworth Lisa D
May/Jun 2002
Pg. 180-181

Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2002
Pg. 202

Bioidentical Hormones in the Treatment of Osteoporosis
Boomsma Diane
Sep/Oct 2001
Pg. 339-341

Basics of Compounding: Suspensions
Allen Loyd V Jr
Jul/Aug 2001
Pg. 294-297

Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Spironolactone Oral Suspension 2-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Progesterone Oral Suspension 40-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Xanthan Gum Oral Suspension Vehicle 0.3%
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
May/Jun 2001
Pg. 198-201

The Basics of Compounding Emulsions, Part 1
Allen Loyd V Jr
Mar/Apr 2001
Pg. 120-123

Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
Jan/Feb 2001
Pg. 38

Milk of Magnesia Concentrate, Unflavored
Allen Loyd V Jr
Jan/Feb 2001
Pg. 47

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

Amphotericin B 100-mg Troches
Allen Loyd V Jr
May/Jun 2000
Pg. 208

Saliva Substitute for Dry Mouth/Throat
Allen Loyd V Jr
May/Jun 2000
Pg. 215

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Osteoarthritis: Other Options
Berrettini Lee
Nov/Dec 1999
Pg. 433-435

Methotrexate 2.5-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1999
Pg. 474

Alternatives for the Lactose-Intolerant Patient
Glasnapp Andrew
Nov/Dec 1998
Pg. 412

Treatment of Skin Aging with Topical Estrogens
Schmidt Jolanta B
, Binder Martina, Demschik Gabriele, Bieglmayer Christian, Reiner Angelika
Jul/Aug 1998
Pg. 270-275

Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form
Johnson Cary E
, Wong Douglas V, Hoppe Heather L, Bhatt-Mehta Varsha
Jul/Aug 1998
Pg. 314-317

Vehicles for Compounding Oral Liquids: Some Practical Considerations
Palmer Henry A
Mar/Apr 1998
Pg. 160-161

Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia
, Henderson Victor W
Jan/Feb 1998
Pg. 24-29

Ketoconazole 20-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1997
Pg. 414

Baclofen 10-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 321

Captopril 0.75-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 322

Diltiazem HCl 12-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 1997
Pg. 323

Metolazone 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 1997
Pg. 329

Stability of Bethanechol Chloride Oral Liquid Dosage Forms
Gupta Vishnu D
, Maswoswe J
Jul/Aug 1997
Pg. 278-279

Creative Compounding for the Geriatric Patient
Allen Loyd V Jr
May/Jun 1997
Pg. 147-148

Drug Products and Drug Packaging for the Elderly
Allen Loyd V Jr
May/Jun 1997
Pg. 150-151

Common Diseases of the Elderly
Allen Loyd V Jr
May/Jun 1997
Pg. 152

Allopurinol 20-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 174

Dipyridamole 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 176

Labetalol HCl 40-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 179

Metoprolol Tartrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 180

Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 183

Spironolactone 25-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 184

Verapamil HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 188

Metronidazole 15-mg/mL Suspension
Gupta Vishnu D
, Maswoswe J, Bailey RE
May/Jun 1997
Pg. 202

Acetazolamide 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 101

Azathioprine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 102

Flecainide Acetate 20-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 103

Methylcellulose 1% to 5% Solutions
Allen Loyd V Jr
Mar/Apr 1997
Pg. 104

Methylcellulose Oral-Liquid Vehicles
Allen Loyd V Jr
Mar/Apr 1997
Pg. 105

Procainamide HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 110

Syrup NF
Allen Loyd V Jr
Mar/Apr 1997
Pg. 111

Tetracaine 20-mg Lollipops
Allen Loyd V Jr
Mar/Apr 1997
Pg. 112

Tetracycline Compound Troche
Allen Loyd V Jr
Mar/Apr 1997
Pg. 113

Xanthan Gum Suspension Vehicle (0.2% to 0.5%)
Allen Loyd V Jr
Mar/Apr 1997
Pg. 114

Stability of Allopurinol Suspension Compounded from Tablets
Alexander Kenneth S
, Davar Nipun, Parker Gordon A
Mar/Apr 1997
Pg. 128-131

Hospice Care and the Pharmacist
Allen Loyd V Jr
Jan/Feb 1997
Pg. 10-12

Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
Jan/Feb 1997
Pg. 13

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Alexander Kenneth S
, Kothapalli Madhu R, Dollimor David
Jan/Feb 1997
Pg. 60-63

Return to Top